BioCentury | May 16, 2018
Company News

Management tracks: Novartis, Aileron

...Belgium) and Laboratoris Sanifit S.L. (Palma de Mallorca, Spain). Roivant Sciences GmbH (Basel, Switzerland) hired Salomon...
BioCentury | May 16, 2017
Distillery Therapeutics

Cancer

...10, 2017 doi:10.1126/scitranslmed.aal2668 CONTACT: Irene M. Ghobrial, Harvard Medical School, Boston, Mass. email: irene_ghobrial@dfci.harvard.edu CONTACT: Salomon...
BioCentury | Jul 13, 2015
Emerging Company Profile

Monitoring rejections

...Disease focus: Diagnostic Clinical status: Marketed Founded: 2013 by Stanley Rose, Michael Abecassis and Daniel Salomon...
BioCentury | Jan 16, 2014
Distillery Therapeutics

Indication: Various

...H. et al. Proc. Natl. Acad. Sci. USA; published online Dec. 9, 2013; doi:10.1073/pnas.1320862110 Contact: Salomon...
BioCentury | Jan 28, 2006
Company News

More Chiron shareholders oppose acquisition

...proposed acquisition of the company by Novartis (NVS; SWX:NOVN). CAM, Smith Barney Fund Management and Salomon...
BioCentury | Oct 20, 2003
Finance

Ebb & Flow

...SoundView 's strategy to expand its healthcare footprint. In July, it hired Glen Santangelo from Salomon...
BioCentury | May 19, 2003
Finance

Ebb & Flow

...confirmed that the firm recently let go Ilana Fogelman at Citigroup Capital Markets - formerly Salomon...
BioCentury | Apr 29, 2003
Financial News

Wall Street settlement finalized

...Morgan ($80 million); Merrill Lynch ($200 million); Morgan Stanley ($125 million); Citigroup Global Markets (formerly Salomon...
BioCentury | Apr 21, 2003
Finance

Ebb & Flow

...additional 315,000 shares in the deal. The offering was underwritten by Citigroup Global Markets (formerly Salomon...
BioCentury | Apr 16, 2003
Financial News

Martek raises $75.6 million

...2, when its price was $29.52. The offering was underwritten by Citigroup Global Markets (formerly Salomon...
Items per page:
1 - 10 of 163
BioCentury | May 16, 2018
Company News

Management tracks: Novartis, Aileron

...Belgium) and Laboratoris Sanifit S.L. (Palma de Mallorca, Spain). Roivant Sciences GmbH (Basel, Switzerland) hired Salomon...
BioCentury | May 16, 2017
Distillery Therapeutics

Cancer

...10, 2017 doi:10.1126/scitranslmed.aal2668 CONTACT: Irene M. Ghobrial, Harvard Medical School, Boston, Mass. email: irene_ghobrial@dfci.harvard.edu CONTACT: Salomon...
BioCentury | Jul 13, 2015
Emerging Company Profile

Monitoring rejections

...Disease focus: Diagnostic Clinical status: Marketed Founded: 2013 by Stanley Rose, Michael Abecassis and Daniel Salomon...
BioCentury | Jan 16, 2014
Distillery Therapeutics

Indication: Various

...H. et al. Proc. Natl. Acad. Sci. USA; published online Dec. 9, 2013; doi:10.1073/pnas.1320862110 Contact: Salomon...
BioCentury | Jan 28, 2006
Company News

More Chiron shareholders oppose acquisition

...proposed acquisition of the company by Novartis (NVS; SWX:NOVN). CAM, Smith Barney Fund Management and Salomon...
BioCentury | Oct 20, 2003
Finance

Ebb & Flow

...SoundView 's strategy to expand its healthcare footprint. In July, it hired Glen Santangelo from Salomon...
BioCentury | May 19, 2003
Finance

Ebb & Flow

...confirmed that the firm recently let go Ilana Fogelman at Citigroup Capital Markets - formerly Salomon...
BioCentury | Apr 29, 2003
Financial News

Wall Street settlement finalized

...Morgan ($80 million); Merrill Lynch ($200 million); Morgan Stanley ($125 million); Citigroup Global Markets (formerly Salomon...
BioCentury | Apr 21, 2003
Finance

Ebb & Flow

...additional 315,000 shares in the deal. The offering was underwritten by Citigroup Global Markets (formerly Salomon...
BioCentury | Apr 16, 2003
Financial News

Martek raises $75.6 million

...2, when its price was $29.52. The offering was underwritten by Citigroup Global Markets (formerly Salomon...
Items per page:
1 - 10 of 163